pageId: securebio
verifiedAt: 2026-02-22
totalCitations: 14
verified: 10
broken: 4
unverifiable: 0
citations:
  - footnote: 1
    url: https://securebio.org/
    linkText: SecureBio Official Website — - Organization overview and mission
    claimContext: '|-----------|------------|----------| | **Focus Area** | AI-bio risks + pathogen surveillance | Two divisions: AI team (capability evals) and NAO (wastewater monitoring)[^1] | | **Funding** | Well-funded by EA sources | ≈\$9.4M from <EntityLink id="open-philanthropy">Coefficient Giving</EntityLink> '
    fetchedAt: 2026-02-22T02:26:05.347Z
    httpStatus: 200
    pageTitle: SecureBio - Securing the future against catastrophic pandemics
    contentSnippet: SecureBio - Securing the future against catastrophic pandemics Securing the future against catastrophic pandemics SARS-CoV-2 has demonstrated that the world is profoundly vulnerable to biological threats. Unfortunately, there is reason to believe that future pandemics could be far worse. Due to rapid advances in biotechnology, the number of people able to create and release dangerous pathogens will quickly increase over the coming years. The world is unprepared for widespread access to such powe
    contentLength: 897297
    status: verified
    note: null
  - footnote: 2
    url: https://www.openphilanthropy.org/grants/securebio-general-support/
    linkText: Coefficient Giving - SecureBio General Support — - \$4M grant
    claimContext: '| **Focus Area** | AI-bio risks + pathogen surveillance | Two divisions: AI team (capability evals) and NAO (wastewater monitoring)[^1] | | **Funding** | Well-funded by EA sources | ≈\$9.4M from <EntityLink id="open-philanthropy">Coefficient Giving</EntityLink> across multiple grants[^2][^3][^4] | |'
    fetchedAt: 2026-02-22T02:26:11.418Z
    httpStatus: 503
    pageTitle: null
    contentSnippet: null
    contentLength: 0
    status: broken
    note: HTTP 503
  - footnote: 3
    url: https://www.openphilanthropy.org/grants/securebio-nucleic-acid-observatory/
    linkText: Coefficient Giving - SecureBio NAO — - \$3.43M grant
    claimContext: '| **Focus Area** | AI-bio risks + pathogen surveillance | Two divisions: AI team (capability evals) and NAO (wastewater monitoring)[^1] | | **Funding** | Well-funded by EA sources | ≈\$9.4M from <EntityLink id="open-philanthropy">Coefficient Giving</EntityLink> across multiple grants[^2][^3][^4] | |'
    fetchedAt: 2026-02-22T02:26:11.329Z
    httpStatus: 503
    pageTitle: null
    contentSnippet: null
    contentLength: 0
    status: broken
    note: HTTP 503
  - footnote: 4
    url: https://www.openphilanthropy.org/grants/securebio-biosecurity-research/
    linkText: Coefficient Giving - Biosecurity Research — - \$1.42M grant
    claimContext: '| **Focus Area** | AI-bio risks + pathogen surveillance | Two divisions: AI team (capability evals) and NAO (wastewater monitoring)[^1] | | **Funding** | Well-funded by EA sources | ≈\$9.4M from <EntityLink id="open-philanthropy">Coefficient Giving</EntityLink> across multiple grants[^2][^3][^4] | |'
    fetchedAt: 2026-02-22T02:26:11.762Z
    httpStatus: 503
    pageTitle: null
    contentSnippet: null
    contentLength: 0
    status: broken
    note: HTTP 503
  - footnote: 5
    url: https://www.nist.gov/document/ai-eo-14110-rfi-comments-securebio
    linkText: SecureBio NIST RFI Submission — - AI policy recommendations
    claimContext: '| **Funding** | Well-funded by EA sources | ≈\$9.4M from <EntityLink id="open-philanthropy">Coefficient Giving</EntityLink> across multiple grants[^2][^3][^4] | | **Policy Influence** | Growing | Virology Capabilities Test adopted by major AI labs; NIST AI Safety Consortium member[^5] | | **Team** |'
    fetchedAt: 2026-02-22T02:26:04.972Z
    httpStatus: 200
    pageTitle: (PDF document)
    contentSnippet: null
    contentLength: 351914
    status: verified
    note: null
  - footnote: 6
    url: https://securebio.org/team/
    linkText: SecureBio Team Page — - Staff and organizational structure
    claimContext: "| **Policy Influence** | Growing | Virology Capabilities Test adopted by major AI labs; NIST AI Safety Consortium member[^5] | | **Team** | ≈25 staff | Experienced leadership from MIT, biosecurity, and operations backgrounds[^6] | | **Key Concern** | Information hazard balance | Biosecurity research"
    fetchedAt: 2026-02-22T02:26:13.027Z
    httpStatus: 200
    pageTitle: SecureBio - Team
    contentSnippet: SecureBio - Team Meet our team Current members Show all NAO Operations Leadership AI Board of Directors Policy Alessandro Zulli Research Scientist NAO Alvaro Morales Director of Operations Operations Leadership Andrew Liu Senior Research Scientist AI Ben Mueller Executive Director Board of Directors Leadership Policy AI Bryce Cai Senior Research Engineer AI Chris Doering Genomic Biosecurity Scientist NAO Christine Parthemore CEO, Council on Strategic Risks Board of Directors Coleman Breen Senior
    contentLength: 949070
    status: verified
    note: null
  - footnote: 7
    url: https://thebulletin.org/2025/03/biosecurity-community-divided-over-best-ways-to-mitigate-risks/
    linkText: Bulletin of the Atomic Scientists - Biosecurity Community Divided — - Information hazard debates
    claimContext: "| **Team** | ≈25 staff | Experienced leadership from MIT, biosecurity, and operations backgrounds[^6] | | **Key Concern** | Information hazard balance | Biosecurity research inherently involves dual-use knowledge[^7] |"
    fetchedAt: 2026-02-22T02:26:13.213Z
    httpStatus: 200
    pageTitle: Biosecurity community divided over best ways to mitigate risks - Bulletin of the Atomic Scientists
    contentSnippet: Biosecurity community divided over best ways to mitigate risks - Bulletin of the Atomic Scientists About Magazine Events Contact Store My Account Login Donate Give Now Ways To Give What Your Gift Supports Annual Event Einstein Circle Legacy Society Donor-Advised Fund Biosecurity community divided over best ways to mitigate risks By Anemone Franz | Voices of Tomorrow | March 20, 2025 Modified photo from depositphotos.com Share Copy link Linked copied Email Facebook Bluesky Twitter LinkedIn WhatsA
    contentLength: 270409
    status: verified
    note: null
  - footnote: 8
    url: https://www.founderspledge.com/research/secure-bio
    linkText: Founders Pledge - SecureBio Assessment — - Impact evaluation
    claimContext: "SecureBio is a 501(c)(3) nonprofit founded in 2022 by Kevin Esvelt, an MIT professor who invented CRISPR-based gene drive technology.[^1] The organization works to protect against catastrophic pandemics—both natural and engineered—through a three-part framework: **Delay** dangerous capability <Entit"
    fetchedAt: 2026-02-22T02:26:13.559Z
    httpStatus: 200
    pageTitle: SecureBio
    contentSnippet: "SecureBio Related research Global Catastrophic Biological Risks: A Guide for Philanthropists Learn more SecureBio is a nonprofit organization that seeks to use new technologies and policy advocacy to protect society against extreme biological risks. 1 SecureBio explains its mission on its website as follows: “SARS-CoV-2 has demonstrated that the world is profoundly vulnerable to biological threats. Unfortunately, there is reason to believe that future pandemics could be far worse. Due to rapid a"
    contentLength: 162720
    status: verified
    note: null
  - footnote: 9
    url: https://forum.effectivealtruism.org/posts/C2ygbqWWzF8MGfcoL/
    linkText: EA Forum - SecureBio Notes from SoGive — - Independent assessment
    claimContext: SecureBio was founded by Kevin Esvelt, who brought credibility from his work on gene drive technology and his security-minded approach to biotechnology. Esvelt had previously argued that the "security mindset was not sufficiently present in most of the bioengineering industry."[^9]
    fetchedAt: 2026-02-22T02:26:12.901Z
    httpStatus: 200
    pageTitle: SecureBio - Notes from SoGive — EA Forum
    contentSnippet: SecureBio - Notes from SoGive — EA Forum This website requires javascript to properly function. Consider activating javascript to get access to all site functionality. Hide table of contents SecureBio - Notes from SoGive by SoGive , Sanjay , Spencer R. Ericson May 6 2024 4 min read 3 4 Biosecurity Existential risk Effective giving SoGive Frontpage SecureBio - Notes from SoGive Current work The interplay between AI and bio threats Counterfactual impact SecureBio’s risk analysis 3 comments Call no
    contentLength: 195656
    status: verified
    note: null
  - footnote: 10
    url: https://www.openphilanthropy.org/grants/securebio-pathogen-early-warning-project/
    linkText: Coefficient Giving - Pathogen Early Warning — - \$570K grant
    claimContext: "- **\\$1,420,937** for biosecurity research over three years[^4] - **\\$570,000** for pathogen early warning systems[^10]"
    fetchedAt: 2026-02-22T02:26:18.826Z
    httpStatus: 429
    pageTitle: null
    contentSnippet: null
    contentLength: 0
    status: broken
    note: HTTP 429
  - footnote: 11
    url: https://securebio.substack.com/p/letter-from-the-executive-director
    linkText: Letter from the Executive Director - SecureBio Substack — - Leadership transition and current status
    claimContext: In September 2024, Kevin Esvelt stepped back from SecureBio's Board to focus on his MIT professorship and academic research, though he remains involved as a co-founder.[^11] Dr. Benjamin Mueller, formerly COO, became Executive Director and Chairman of the Board.
    fetchedAt: 2026-02-22T02:26:20.292Z
    httpStatus: 200
    pageTitle: Letter from the Executive Director - SecureBio
    contentSnippet: "Letter from the Executive Director - SecureBio SecureBio Subscribe Sign in Letter from the Executive Director Some recent organizational updates SecureBio May 23, 2025 1 Share I write with an overview of SecureBio’s progress towards mitigating catastrophic biorisks and advancing biosecurity, and changes to our Board of Directors. Since we set up the organization in 2022, we have made major strides in two of our focus areas: Working to delay the onset of the next pandemic by analyzing the capabil"
    contentLength: 133367
    status: verified
    note: null
  - footnote: 12
    url: https://arxiv.org/html/2504.16137v2
    linkText: Virology Capabilities Test Paper — - AI virology benchmark results
    claimContext: The team developed the **Virology Capabilities Test (VCT)**, a benchmark measuring AI models' ability to assist with complex virology tasks. A 2025 study using the VCT found that <EntityLink id="openai">OpenAI</EntityLink>'s o3 model "outperformed 94 percent of expert virologists" on troubleshooting
    fetchedAt: 2026-02-22T02:26:21.428Z
    httpStatus: 200
    pageTitle: "Virology Capabilities Test (VCT): A Multimodal Virology Q&A Benchmark"
    contentSnippet: "Virology Capabilities Test (VCT): A Multimodal Virology Q&A Benchmark \\titlecontents section[2em] \\contentslabel 2em \\titlerule *[.5em]. \\contentspage [] Virology Capabilities Test (VCT): A Multimodal Virology Q&A Benchmark Jasper Götting a SecureBio Pedro Medeiros a SecureBio Center for Natural and Human Sciences, Federal University of ABC Jon G Sanders a SecureBio Nathaniel Li † Long Phan Center for AI Safety Karam Elabd SecureBio Lennart Justen Media Lab, Massachusetts Institute of Technology"
    contentLength: 1057452
    status: verified
    note: null
  - footnote: 13
    url: https://forum-bots.effectivealtruism.org/posts/C2ygbqWWzF8MGfcoL/
    linkText: SoGive Notes on SecureBio — - Funding and operational details
    claimContext: The AI-Bio evaluation project alone costs approximately **\$700,000 per 6 months**, covering team leads, policy scientists, contractors, and research assistants.[^13] As of early 2024, SecureBio was actively seeking additional funding to sustain operations.[^13]
    fetchedAt: 2026-02-22T02:26:21.608Z
    httpStatus: 200
    pageTitle: SecureBio - Notes from SoGive — EA Forum Bots
    contentSnippet: SecureBio - Notes from SoGive — EA Forum Bots This website requires javascript to properly function. Consider activating javascript to get access to all site functionality. Hide table of contents SecureBio - Notes from SoGive by SoGive , Sanjay , Spencer R. Ericson May 6 2024 4 min read 3 4 Biosecurity Existential risk Effective giving SoGive Frontpage SecureBio - Notes from SoGive Current work The interplay between AI and bio threats Counterfactual impact SecureBio’s risk analysis 3 comments Ca
    contentLength: 192117
    status: verified
    note: null
  - footnote: 14
    url: https://securebio.substack.com/p/nao-updates-november-2025
    linkText: NAO Updates November 2025 — - Current scale and detections
    claimContext: "**Nucleic Acid Observatory (NAO)**: Uses untargeted metagenomic sequencing of wastewater to identify new and unknown pathogens—including those with extended incubation periods that evade symptom-based surveillance. As of November 2025, NAO monitors 31 sampling sites across 19 US cities and 5 US mili"
    fetchedAt: 2026-02-22T02:26:20.374Z
    httpStatus: 200
    pageTitle: NAO Updates, November 2025 - SecureBio
    contentSnippet: NAO Updates, November 2025 - SecureBio SecureBio Subscribe Sign in NAO Updates, November 2025 SecureBio Nov 12, 2025 4 Share Since July , we’ve made major strides in scaling CASPER , expanding Zephyr , and automating our analysis systems. As always, if you have questions or see opportunities to collaborate, please let us know; we’re eager to work with others thinking along similar lines. Wastewater Sequencing Our collaboration with Marc Johnson , Dave O’Connor , Rachel Poretsky , Jason Rothman ,
    contentLength: 157563
    status: verified
    note: null
